MORGENS WATERFALL VINTIADIS & CO INC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGENS WATERFALL VINTIADIS & CO INC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$427,000
-57.3%
50,0000.0%0.38%
-42.0%
Q3 2018$1,001,000
-44.2%
50,000
-28.1%
0.66%
-48.5%
Q2 2018$1,795,000
+103.1%
69,500
+87.8%
1.27%
+89.3%
Q1 2018$884,000
-29.5%
37,0000.0%0.67%
-31.9%
Q4 2017$1,254,00037,0000.99%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 657,467$2,709,0002.82%
Healthcare Value Capital, LLC 100,000$412,0001.36%
Opaleye Management Inc. 1,487,800$6,130,0001.20%
Worth Venture Partners, LLC 225,106$927,0000.76%
ARMISTICE CAPITAL, LLC 2,742,000$11,297,0000.41%
DELTEC ASSET MANAGEMENT LLC 355,845$1,466,0000.26%
ESSEX INVESTMENT MANAGEMENT CO LLC 329,437$1,357,0000.19%
Mosaic Family Wealth, LLC 92,357$381,0000.14%
EMERALD ADVISERS, LLC 642,226$2,646,0000.11%
DCF Advisers, LLC 31,236$129,0000.07%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders